Apollomics logo

Apollomics share price today

(APLM)

Apollomics share price is $9.75 & ₹828.52 as on 21 Dec 2024, 2.30 'hrs' IST

$9.75

0.38

(4.06%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Apollomics share price in Dollar and Rupees. Guide to invest in Apollomics from India. Also see the sentimental analysis on Indian investors investing in Apollomics. Get details on the Indian mutual funds that are investing in Apollomics. Get Analyst recommendations and forecasts along with all the Apollomics's financials.

Apollomics share price movements

  • Today's Low: $7.62
    Today's High: $10.47

    Day's Volatility :27.22%

  • 52 Weeks Low: $6.50
    52 Weeks High: $105.00

    52 Weeks Volatility :93.81%

Apollomics Returns

PeriodApollomics IncIndex (Russel 2000)
3 Months
-24.07%
0.0%
6 Months
-55.68%
0.0%
1 Year
-88.11%
0.0%
3 Years
-99.67%
-19.7%

Apollomics Key Statistics

in dollars & INR

Previous Close
$9.37
Open
$8.65
Today's High
$10.47
Today's Low
$7.62
Market Capitalization
$16.5M
Today's Volume
$193.7K
52 Week High
$105.0
52 Week Low
$6.5
Revenue TTM
$2.1M
EBITDA
$-53.1M
Earnings Per Share (EPS)
$-0.15
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-149.31%

How to invest in Apollomics from India?

It is very easy for Indian residents to invest directly in Apollomics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Apollomics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Apollomics or APLM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Apollomics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Apollomics shares which would translate to 0.087 fractional shares of Apollomics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Apollomics, in just a few clicks!

Returns in Apollomics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Apollomics investment value today

Current value as on today

₹1,90,301

Returns

₹90,301

(+90.3%)

Returns from Apollomics Stock

₹88,105 (false-88.11%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Apollomics

-63.47%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Apollomics from India has reduced in the last 30 days as on Dec 21, 2024. -63.47% less purchase transactions for Apollomics in the last 30 days versus the previous period.

18%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Apollomics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 18% more investors are searching Apollomics in the last 30 days versus the previous period.

Analyst Recommendation on Apollomics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Apollomics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Apollomics

What analysts predicted

Downside of 79.49%

Current:

$9.75

Target:

$2.00

Insights on Apollomics

  • Price Movement

    In the last 7 days, APLM stock has moved up by 16.9%
  • APLM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 123.3%
  • Price to Sales

    ForAPLM every $1 of sales, investors are willing to pay $423.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Apollomics Technicals Summary

Sell

Neutral

Buy

Apollomics is currently in a neutral trading position according to technical analysis indicators.

Apollomics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Apollomics Inc
-3.47%
-55.68%
-88.11%
-99.67%
-99.67%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Apollomics Inc
NA
NA
NA
0.0
-1.49
-0.63
NA
0.19
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Apollomics Inc
Buy
$16.5M
-99.67%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Apollomics

formerly known as cbt pharmaceuticals. at apollomics, we are a purpose driven company imagining a world without cancer. we let science drive our decision making to advance our programs. we believe in the power of partnerships to enhance our pipeline and broaden the patient populations we serve. apollomics is committed to the discovery and development of oncology combination therapies. we believe that combination regimens can achieve clinically meaningful, durable responses that will allow us to enhance outcomes for patients. we have in-licensed our assets from multiple partners and built strong collaborations to advance our pre-clinical and clinical development programs. when developing an asset, we begin with rigorous ind-enabling studies to establish sound mechanistic and scientific rationale and guide our development path. this path may be as a monotherapy, a combination therapy, or both. while our ultimate goal is to study each of our assets in combination with other agents, we h
Organization
Apollomics
Employees
45
CEO
Dr. Guo-Liang Yu Ph.D.
Industry
Miscellaneous

Management People of Apollomics

NameTitle
Dr. Guo-Liang Yu Ph.D.
Co-Founder, CEO & Executive Chairman
Dr. Matthew James Plunkett Ph.D.
Chief Financial Officer

Important FAQs about investing in Apollomics from India :

What is Apollomics share price today?

Apollomics share price today stands at $9.75, Open: $8.65 ; Previous Close: $9.37 ; High: $10.47 ; Low: $7.62 ; 52 Week High: $105.00 ; 52 Week Low: $6.50. The stock opens at $8.65, after a previous close of $9.37. The stock reached a daily high of $10.47 and a low of $7.62, with a 52-week high of $105.00 and a 52-week low of $6.50.

Can Indians buy Apollomics shares?

Yes, Indians can invest in the Apollomics (APLM) from India.

With INDmoney, you can buy Apollomics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Apollomics at zero transaction cost.

How can I buy Apollomics shares from India?

It is very easy to buy Apollomics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Apollomics be purchased?

Yes, you can buy fractional shares of Apollomics with INDmoney app.

What are the documents required to start investing in Apollomics stocks?

To start investing in Apollomics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Apollomics

Today’s highest price of Apollomics (APLM) is $10.47.

Today’s lowest price of Apollomics (APLM) is $7.62.

What is today's market capitalisation of Apollomics

Today's market capitalisation of Apollomics APLM is 16.5M

What is the 52 Week High and Low Range of Apollomics

  • 52 Week High

    $105.00

  • 52 Week Low

    $6.50

What are the historical returns of Apollomics?

  • 1 Month Returns

    -3.47%

  • 3 Months Returns

    -55.68%

  • 1 Year Returns

    -88.11%

  • 5 Years Returns

    -99.67%

Who is the Chief Executive Officer (CEO) of Apollomics

Dr. Guo-Liang Yu Ph.D. is the current Chief Executive Officer (CEO) of Apollomics.